Endometrial cancer treatment is rapidly changing, especially with regard to adjuvant therapy. This review will bring you up to speed. Expert Review of Anticancer Therapy
Does tumor vascularity, or expression of vascular endothelial growth factor protein and its receptors, contribute to patient outcomes? Laboratory Investigation
In this Expert Interview from ASCO 2008, Dr. Robert Motzer discusses the evolving role of mTOR inhibition in the treatment of renal cell carcinoma, with a focus on the newest agent in the class. Medscape Hematology-Oncology
Cetuximab combined with cisplatin/vinorelbine showed a small overall survival benefit in patients with advanced non-small-cell lung cancer over chemotherapy alone. Medscape Medical News
